NEUWAY Pharma
PrivateLast Round
Convertible Debt
Jun 16, 2021
Total Funding Raised
$27.69M
Company Overview
NEUWAY Pharma operates in Healthcare & Life Sciences and is based in Bonn. Its latest recorded funding round was a Convertible Debt round in June 2021.
NEUWAY Pharma is a biotechnology company developing therapies for the treatment of central nervous system (CNS) diseases based on its proprietary drug delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NEUWAY Pharma Comparables
Compare NEUWAY Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gate2Brain | 84% | |
| Lauren Sciences LLC | 84% | |
| Ossianix | 79% |
For institutional investors. Book with your work email.
NEUWAY Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jun 16, 2021 | ||||
| Series A | Mar 1, 2018 | ||||
| Grant | Aug 1, 2015 | ||||
| Grant | Apr 1, 2014 |
For institutional investors. Book with your work email.
NEUWAY Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Ministry of Education and Research | Grant |
| Life Science Inkubator | Series A |
| Wellington Partners | Series A |
| KfW Development Bank | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2021
Raised $10M in convertible debt.
- Mar 1, 2018
$11.3M round led by Wellington Partners
For institutional investors. Book with your work email.
NEUWAY Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NEUWAY Pharma's valuation, stock price, and market status.
Is NEUWAY Pharma a public or private company?
NEUWAY Pharma is a private company.
What is the current stock price of NEUWAY Pharma?
NEUWAY Pharma is a private company, so its shares have no public market price. Caplight tracks NEUWAY Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NEUWAY Pharma worth (valuation)?
Valuation information for NEUWAY Pharma is not publicly available.
Can I buy NEUWAY Pharma stock?
NEUWAY Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NEUWAY Pharma's last funding round?
NEUWAY Pharma's most recent funding round was Convertible Debt on June 16, 2021.
Who are the main investors in NEUWAY Pharma?
Key investors in NEUWAY Pharma include Wellington Partners.
Will NEUWAY Pharma IPO soon?
No public IPO plans have been announced for NEUWAY Pharma.
How can I track NEUWAY Pharma secondary market activity?
Caplight tracks bids, offers, and trades in NEUWAY Pharma's shares on secondary markets.